{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:35:07Z","timestamp":1761708907819,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.purol.2013.08.321","type":"journal-article","created":{"date-parts":[[2013,10,2]],"date-time":"2013-10-02T03:00:55Z","timestamp":1380682855000},"page":"1265-1270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chimioth\u00e9rapie des organes g\u00e9nitaux externes chez l\u2019homme (cancer du testicule et du p\u00e9nis)"],"prefix":"10.1016","volume":"23","author":[{"given":"J.-L.","family":"Deville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Flechon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bruy\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Karsenty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Guy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bastide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2013.08.321_bib0005","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1200\/JCO.2009.26.4655","article-title":"Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19\/EORTC 30982\u00a0study (ISRCTN27163214)","volume":"29","author":"Oliver","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2013.08.321_bib0010","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0022-5347(01)61615-X","article-title":"Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors","volume":"161","author":"B\u00f6hlen","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2013.08.321_bib0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.eururo.2004.03.022","article-title":"Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and\/or vascular invasion","volume":"46","author":"Chevreau","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2013.08.321_bib0020","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1200\/JCO.1996.14.4.1106","article-title":"Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report","volume":"14","author":"Cullen","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2013.08.321_bib0025","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0022-5347(17)36937-9","article-title":"Pilot study to evaluate impact of a policy of adjuvant chemotherapy for high risk stage 1\u00a0malignant teratoma on overall relapse rate of stage 1\u00a0cancer patients","volume":"148","author":"Oliver","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2013.08.321_bib0030","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.1996.14.2.441","article-title":"Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial","volume":"14","author":"Pont","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2013.08.321_bib0035","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1159\/000474650","article-title":"Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer","volume":"23","author":"Studer","year":"1993","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2013.08.321_bib0040","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1200\/JCO.2007.15.9103","article-title":"Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study","volume":"26","author":"Garcia-del-Muro","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2013.08.321_bib0045","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1200\/JCO.2009.26.8128","article-title":"Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy","volume":"28","author":"Lorch","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2013.08.321_bib0050","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/annonc\/mdq021","article-title":"Poor prognosis nonseminomatous germ-cell tumours (NSGCTs): should chemotherapy doses be reduced at first cycle to prevent acute respiratory distress syndrome in patients with multiple lung metastases?","volume":"21","author":"Massard","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.purol.2013.08.321_bib0055","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1200\/JCO.1997.15.4.1427","article-title":"Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma","volume":"15","author":"Miller","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2013.08.321_bib0060","first-page":"829","article-title":"Chemotherapy of penile carcinomas","volume":"15","author":"Culine","year":"2005","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2013.08.321_bib0065","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.juro.2006.11.038","article-title":"Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma","volume":"177","author":"Bermejo","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2013.08.321_bib0070","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant paclitaxel, ifosfamide, and cisplatine chemotherapy for metastatic penile cancer: a phase II study","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2013.08.321_bib0075","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.eururo.2008.07.014","article-title":"Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results","volume":"55","author":"Pizzocaro","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2013.08.321_bib0080","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1464-410X.2006.06496.x","article-title":"Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma","volume":"98","author":"Hakenberg","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2013.08.321_bib0085","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-5347(17)38069-2","article-title":"Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract","volume":"146","author":"Dexeus","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2013.08.321_bib0090","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0022-5347(01)62402-9","article-title":"Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin","volume":"160","author":"Corral","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2013.08.321_bib0095","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0022-5347(05)68815-5","article-title":"Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study","volume":"161","author":"Haas","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2013.08.321_bib0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/1097-0142(19900201)65:3<433::AID-CNCR2820650310>3.0.CO;2-G","article-title":"Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas","volume":"65","author":"Hussein","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.purol.2013.08.321_bib0105","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1464-410X.2012.11453.x","article-title":"Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis","volume":"110","author":"Di Lorenzo","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2013.08.321_bib0110","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.eururo.2011.08.028","article-title":"Paclitaxel in pretreated metastatic penile cancer: final results of a phase II study","volume":"60","author":"Di Lorenzo","year":"2011","journal-title":"Eur Urol"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708713006581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708713006581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:23:41Z","timestamp":1761114221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708713006581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":22,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1166708713006581"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2013.08.321","relation":{},"ISSN":["1166-7087"],"issn-type":[{"type":"print","value":"1166-7087"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimioth\u00e9rapie des organes g\u00e9nitaux externes chez l\u2019homme (cancer du testicule et du p\u00e9nis)","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2013.08.321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}